A detailed history of First Republic Investment Management, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, First Republic Investment Management, Inc. holds 52,516 shares of VRTX stock, worth $23.7 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
52,516
Previous 33,790 55.42%
Holding current value
$23.7 Million
Previous $11.9 Million 53.57%
% of portfolio
0.05%
Previous 0.06%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

BUY
$338.18 - $362.46 $6.33 Million - $6.79 Million
18,726 Added 55.42%
52,516 $18.3 Million
Q2 2023

Jul 28, 2023

SELL
$314.42 - $351.91 $1.38 Million - $1.54 Million
-4,386 Reduced 11.49%
33,790 $11.9 Million
Q1 2023

May 11, 2023

SELL
$283.23 - $323.1 $606,678 - $692,080
-2,142 Reduced 5.31%
38,176 $12 Million
Q4 2022

Feb 13, 2023

SELL
$285.76 - $321.48 $1.1 Million - $1.24 Million
-3,842 Reduced 8.7%
40,318 $11.6 Million
Q3 2022

Nov 03, 2022

BUY
$273.83 - $305.53 $3.51 Million - $3.92 Million
12,826 Added 40.93%
44,160 $12.8 Million
Q2 2022

Aug 16, 2022

SELL
$234.96 - $292.55 $416,349 - $518,398
-1,772 Reduced 5.35%
31,334 $8.83 Million
Q1 2022

May 16, 2022

BUY
$221.42 - $260.97 $592,077 - $697,833
2,674 Added 8.79%
33,106 $8.64 Million
Q4 2021

Feb 09, 2022

BUY
$177.01 - $223.45 $4.12 Million - $5.2 Million
23,254 Added 323.96%
30,432 $6.68 Million
Q3 2021

Nov 12, 2021

BUY
$181.39 - $202.99 $283,149 - $316,867
1,561 Added 27.79%
7,178 $1.3 Million
Q2 2021

Aug 16, 2021

BUY
$187.49 - $221.1 $270,548 - $319,047
1,443 Added 34.57%
5,617 $1.13 Million
Q1 2021

May 14, 2021

SELL
$207.02 - $241.31 $273,059 - $318,287
-1,319 Reduced 24.01%
4,174 $897,000
Q4 2020

Feb 16, 2021

SELL
$207.01 - $276.09 $4.32 Million - $5.76 Million
-20,852 Reduced 79.15%
5,493 $1.3 Million
Q3 2020

Nov 12, 2020

BUY
$255.65 - $303.1 $5.38 Million - $6.38 Million
21,039 Added 396.51%
26,345 $7.17 Million
Q2 2020

Aug 13, 2020

BUY
$225.48 - $295.8 $63,585 - $83,415
282 Added 5.61%
5,306 $1.54 Million
Q1 2020

May 13, 2020

SELL
$199.77 - $247.81 $150,227 - $186,353
-752 Reduced 13.02%
5,024 $1.2 Million
Q4 2019

Feb 14, 2020

SELL
$166.71 - $223.91 $474,790 - $637,695
-2,848 Reduced 33.02%
5,776 $1.27 Million
Q3 2019

Nov 08, 2019

SELL
$166.23 - $187.09 $354,568 - $399,062
-2,133 Reduced 19.83%
8,624 $1.46 Million
Q2 2019

Aug 07, 2019

SELL
$164.61 - $190.37 $1.58 Million - $1.83 Million
-9,617 Reduced 47.2%
10,757 $1.97 Million
Q1 2019

Apr 30, 2019

SELL
$163.73 - $194.7 $71,877 - $85,473
-439 Reduced 2.11%
20,374 $3.75 Million
Q4 2018

Feb 12, 2019

SELL
$151.91 - $192.21 $2.21 Million - $2.8 Million
-14,579 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$167.73 - $192.74 $23,314 - $26,790
-139 Reduced 0.94%
14,579 $2.81 Million
Q2 2018

Aug 14, 2018

BUY
$145.72 - $169.96 $2.14 Million - $2.5 Million
14,718 New
14,718 $2.5 Million
Q1 2018

May 10, 2018

BUY
$151.6 - $177.13 $46,844 - $54,733
309 Added 2.69%
11,786 $1.92 Million
Q4 2017

Feb 09, 2018

SELL
$137.28 - $155.55 $1.74 Million - $1.97 Million
-12,643 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$148.13 - $162.24 $1.87 Million - $2.05 Million
12,643
12,643 $1.92 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track First Republic Investment Management, Inc. Portfolio

Follow First Republic Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.